Exploring Emotion and Emotional Variability as Digital Biomarkers in Frontotemporal Dementia Speech

Frontotemporal Dementia (FTD) encompasses a range of progressive neurodegenerative conditions that impair speech production and comprehension, higher cognitive functions, behavior, and motor skills. Considerable research has focused on conventional acoustic speech markers in FTD, as well as assessments of apathy and challenges in emotion recognition and expression.

In this study, Redenlab has collaborated with the University of Melbourne, Monash University, and the Massachusetts Institute of Technology.

For more information about the study, please click here.

Related Post

  • Posted on 14 October, 2024
    Redenlab is pleased to announce that Dr. Adam Vogel, an expert in speech and language function, will be presenting at...
    • Posted on 4 September, 2024
      Dr. Adam Vogel, CSO of Redenlab, will be speaking alongside Dr. Tairmae Kangarloo, Associate Director of Digital Strategy at Takeda,...
      • Posted on 3 September, 2024
        Redenlab is proud to announce our participation in the 14th International Conference on Frontotemporal Dementias (ICFTD), to be held in...